Pharma & Biotech
GSRX Industries, a Chemesis International subsidiary, blazes into 2020 with strong portfolio of cannabis assets
Acasti Pharma eyeing FDA meeting as it continues to advance heart disease candidate CaPre
The Green Organic Dutchman tackles Canada's recreational cannabis market as it powers ahead
Only registered members can use this feature.
Copyright © Proactive Investors 2020.
All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC.